MBDB refers to a chemical substance called Methylbenzodioxolylbutanamine. It is classified as a stimulant and psychedelic chemical but is only used for research and not for human consumption. This simply means that the commercial use of this drug is prohibited and it should be used solely for the purpose of laboratory research.

MBDB is part of phenethylamine’s chemical group and closely resembles the properties of another chemical called MDMA or methylenedioxymethampetamine. MBDB is said to contain high values of dopamine and norepinephrine which are potent psychogenic drugs. With its association to high potency and psychedelic effects, drugs containing the MBDB active ingredient are prohibited and illegal for human use. Dosage of the chemical is also not even determined since this particular substance is used only for research purposes.

The first MBDB was synthesized by a top pharmacologist named David E. Nichols and this same chemical was later tested and studied by Alexander Shulgin. According to Shulgin’s research findings, MDBD’s supposed ideal dosage is 180-210 mg but may not be applied for human consumption since factors such as body mass must be considered. The drug’s effect is also said to last for up to 6 hours and these include psychogenic symptoms like elevated empathy and compassion for others, higher than normal sense of self or improved mood, lowered social inhibitions, and a feeling of euphoria. These symptoms are said to milder but very similar to the effects of MDMA. With its seemingly milder psychogenic effects, some experts have suggested that this chemical may be better off as a therapeutic drug when compared to MDMA. There is still no recommendation however that MBDB may be allowed for human consumption. At present, its status remains as a drug or chemical for research purposes only. As for the medical and scientific community, there is not enough studies on MBDB in terms of its effects and adverse reactions to make it suitable for some human conditions.